Accelerate Diagnostics, Inc. filed for Chapter 11 bankruptcy on May 8, 2025, and entered into an asset purchase agreement on May 30, 2025, to sell its assets to Indaba Capital Management for approximately $41.95 million. This transaction is pending court approval and is part of a process to handle their financial obligations.